Evaluation of markers of outcome in real-world treatment of diabetic macular edema
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/107595 https://doi.org/10.1186/s40662-018-0119-9 |
Resumo: | Objective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME. |
id |
RCAP_fe3c5a31eca20ab08bb49b7fb5cc81df |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/107595 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Evaluation of markers of outcome in real-world treatment of diabetic macular edemaDiabetic macular edemaOutcome factorsSpectral-domain optical coherence tomographyAntivascular endothelial growth factorLaserObjective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME.Springer Nature2018info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107595http://hdl.handle.net/10316/107595https://doi.org/10.1186/s40662-018-0119-9eng2326-025430386806Campos, AntónioCampos, Elisa J.Carmo, Anália doCaramelo, FranciscoMartins, JoãoSousa, João P.Ambrósio, AntónioSilva, Rufinoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T10:05:40Zoai:estudogeral.uc.pt:10316/107595Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:55.846566Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
title |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
spellingShingle |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema Campos, António Diabetic macular edema Outcome factors Spectral-domain optical coherence tomography Antivascular endothelial growth factor Laser |
title_short |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
title_full |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
title_fullStr |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
title_full_unstemmed |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
title_sort |
Evaluation of markers of outcome in real-world treatment of diabetic macular edema |
author |
Campos, António |
author_facet |
Campos, António Campos, Elisa J. Carmo, Anália do Caramelo, Francisco Martins, João Sousa, João P. Ambrósio, António Silva, Rufino |
author_role |
author |
author2 |
Campos, Elisa J. Carmo, Anália do Caramelo, Francisco Martins, João Sousa, João P. Ambrósio, António Silva, Rufino |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Campos, António Campos, Elisa J. Carmo, Anália do Caramelo, Francisco Martins, João Sousa, João P. Ambrósio, António Silva, Rufino |
dc.subject.por.fl_str_mv |
Diabetic macular edema Outcome factors Spectral-domain optical coherence tomography Antivascular endothelial growth factor Laser |
topic |
Diabetic macular edema Outcome factors Spectral-domain optical coherence tomography Antivascular endothelial growth factor Laser |
description |
Objective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/107595 http://hdl.handle.net/10316/107595 https://doi.org/10.1186/s40662-018-0119-9 |
url |
http://hdl.handle.net/10316/107595 https://doi.org/10.1186/s40662-018-0119-9 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2326-0254 30386806 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Springer Nature |
publisher.none.fl_str_mv |
Springer Nature |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134125206011904 |